Ignite Creation Date:
2024-05-06 @ 5:53 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05463263
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2022-06-30
Brief Title:
A Phase 12 Study of STP938 for Adult Subjects With RelapsedRefractory B-Cell and T-Cell Lymphomas
Sponsor:
Step Pharma SAS
Organization:
Step Pharma SAS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-03
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-30
First Submit QC Date:
July 14 2022
Study First Post Date:
2022-07-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-19
Last Update Post Date:
2023-09-21
Last Update Post Date Type:
ACTUAL